alanine has been researched along with Deglutition Disorders in 3 studies
Alanine: A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM.
alanine : An alpha-amino acid that consists of propionic acid bearing an amino substituent at position 2.
Deglutition Disorders: Difficulty in SWALLOWING which may result from neuromuscular disorder or mechanical obstruction. Dysphagia is classified into two distinct types: oropharyngeal dysphagia due to malfunction of the PHARYNX and UPPER ESOPHAGEAL SPHINCTER; and esophageal dysphagia due to malfunction of the ESOPHAGUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Safinamide is a monoamine oxidase B (MAOB) inhibitor that facilitates CDS." | 5.91 | The effects of safinamide on dysphagia in Parkinson's disease. ( Hirano, M; Isono, C; Nagai, Y; Samukawa, M, 2023) |
| "Safinamide is a monoamine oxidase B (MAOB) inhibitor that facilitates CDS." | 1.91 | The effects of safinamide on dysphagia in Parkinson's disease. ( Hirano, M; Isono, C; Nagai, Y; Samukawa, M, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Hirano, M | 1 |
| Samukawa, M | 1 |
| Isono, C | 1 |
| Nagai, Y | 1 |
| Moore, SE | 1 |
| Huesgen, E | 1 |
| Howe, Z | 1 |
| Yoshinaga, T | 1 |
| Sekijima, Y | 1 |
| Koyama, S | 1 |
| Maruyama, K | 1 |
| Yoshida, T | 1 |
| Kato, T | 1 |
| Ikeda, S | 1 |
3 other studies available for alanine and Deglutition Disorders
| Article | Year |
|---|---|
The effects of safinamide on dysphagia in Parkinson's disease.
Topics: Alanine; Antiparkinson Agents; Benzylamines; Deglutition Disorders; Humans; Levodopa; Monoamine Oxid | 2023 |
Sustained virologic suppression with abacavir, emtricitabine, and crushed dolutegravir and tenofovir alafenamide in a patient with HIV and eosinophilic esophagitis.
Topics: Adult; Alanine; Anti-HIV Agents; Deglutition Disorders; Dideoxynucleosides; Drug Therapy, Combinatio | 2020 |
Clinical and radiological findings of a cerebrotendinous xanthomatosis patient with a novel p.A335V mutation in the CYP27A1 gene.
Topics: Achilles Tendon; Alanine; Ataxia; Brain; Cataract; Chenodeoxycholic Acid; Cholestanetriol 26-Monooxy | 2014 |